What is TigerConnect?
TigerConnect offers a comprehensive suite of healthcare collaboration and clinical communication software designed to streamline care team workflows. The platform facilitates secure messaging, automated alerts, intelligent message routing, and ultimately aims to enhance patient outcomes. By supporting secure communication, scheduling, alarm management, patient engagement, and workflow orchestration, TigerConnect empowers hospitals and various care settings to improve operational efficiency and patient care coordination.
How much funding has TigerConnect raised?
TigerConnect has raised a total of $126.1M across 5 funding rounds:
Angel/Seed
$1.9M
Series A
$8.2M
Series B
$21M
Series C
$50M
Series D
$45M
Angel/Seed (2010): $1.9M with participation from Herb Madan and Bert Ellis
Series A (2012): $8.2M led by Easton Capital and New Science Ventures
Series B (2014): $21M supported by Reed Elsevier Ventures, OrbiMed, TELUS Corporation, and Shasta Ventures
Series C (2015): $50M featuring Reed Elsevier Ventures, OrbiMed, Norwest Venture Partners, Accolade Partners, Invus Group, and Shasta Ventures
Series D (2020): $45M backed by Industry Ventures, Invus, New Leaf Ventures, HealthQuest Capital, Norwest Venture Partners, and Montreux Growth Partners
Key Investors in TigerConnect
Reed Elsevier Ventures
Founded in 2000, Reed Elsevier Ventures is a London-based venture capital firm backed by Reed Elsevier, focusing on investing in entrepreneurs and management teams with the vision to build great companies. They actively participate in company development through their extensive industry network.
OrbiMed
OrbiMed Advisors LLC is a specialized investment firm with deep expertise in the healthcare sector, managing capital across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services. They support companies at various development stages with a comprehensive understanding of healthcare innovation.
Norwest Venture Partners
Norwest Venture Partners is a global, multi-stage venture capital and growth equity investment firm founded in 1961, with headquarters in Palo Alto, California, and offices in India and Israel.
What's next for TigerConnect?
The significant enterprise-level backing TigerConnect has received indicates a strong market validation and positions the company for accelerated expansion. This capital infusion is likely to fuel further development of its innovative communication platform, enhance its market penetration, and potentially support strategic acquisitions or partnerships. The company's focus on improving clinical workflows and patient outcomes suggests a continued emphasis on technological advancement and service expansion within the healthcare industry.
See full TigerConnect company page
